HST
53
4
UNP
38
5
NWSA
69
4
FMC
23
7
PSX
24
2
STX
34
2
NWS
69
5
CCL
68
6
ROK
46
3
UHS
50
4
HAL
40
11
AEP
45
5
HCP
54
2
SYK
50
4
GME
61
2
KHC
11
2
AAPL
64
3
CAG
34
3
STT
48
4
WAT
55
11
HST
53
4
UNP
38
5
NWSA
69
4
FMC
23
7
PSX
24
2
STX
34
2
NWS
69
5
CCL
68
6
ROK
46
3
UHS
50
4
HAL
40
11
AEP
45
5
HCP
54
2
SYK
50
4
GME
61
2
KHC
11
2
AAPL
64
3
CAG
34
3
STT
48
4
WAT
55
11
Financhill
Back

Biodexa Pharmaceuticals PLC 10K Form

Sell
26

BDRX
Biodexa Pharmaceuticals PLC

Last Price:
$3.93
Seasonality Move:
-9.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BDRX News And Ratings

See the #1 stock for the next 7 days that we like better than BDRX

BDRX Financial Statistics

Sales & Book Value

Annual Sales: $474.1K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $30.44
Price / Book: 0.21

Profitability

EPS (TTM): -74.59720
Net Income (TTM): $-8.5M
Gross Margin: $-4.6M
Return on Equity: 0%
Return on Assets: 0%

Biodexa Pharmaceuticals PLC Earnings Forecast

Key Biodexa Pharmaceuticals PLC Financial Ratios

  • The Gross Profit Margin over the past 11 years for BDRX is -967.45%.
  • The Selling, General & Administrative Expenses for BDRX have been equal to 1,139.63% of Gross Profit Margin.
  • The Interest Expense is -0.58% of Operating Income.
  • The Net Earning history of BDRX is -1,857.99% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 6 years.

Biodexa Pharmaceuticals PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BDRX
Website: biodexapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BDRX Technical Analysis vs Fundamental Analysis

Sell
26
Biodexa Pharmaceuticals PLC (BDRX) is a Sell

Is Biodexa Pharmaceuticals PLC a Buy or a Sell?